613 results on '"Choi, Jay Chol"'
Search Results
2. Differential impacts of admission LDL-cholesterol on early vascular outcomes by ischemic stroke subtypes
3. Effect of Transport Time on the Use of Reperfusion Therapy for Patients with Acute Ischemic Stroke in Korea.
4. D-dimer to fibrinogen ratio predicts early neurological deterioration in ischemic stroke with atrial fibrillation
5. Admission LDL-cholesterol, statin pretreatment and early outcomes in acute ischemic stroke
6. Improvement in Delivery of Ischemic Stroke Treatments but Stagnation of Clinical Outcomes in Young Adults in South Korea
7. Efficacy and safety of oxiracetam in patients with vascular cognitive impairment: A multicenter, randomized, double-blinded, placebo-controlled, phase IV clinical trial
8. Frequency, management, and outcomes of early neurologic deterioration due to stroke progression or recurrence
9. Admission hyperglycemia, stroke subtypes, outcomes in acute ischemic stroke
10. Underweight predicts poststroke cardiovascular events in patients without atrial fibrillation
11. Differential influences of LDL cholesterol on functional outcomes after intravenous thrombolysis according to prestroke statin use
12. Temporal Trends in Stroke Management and Outcomes between 2011 and 2020: Results from a Nationwide Multicenter Registry
13. Abstract TMP107: Persistent Beta-Blocker Use and Mortality Reduction in Acute Ischemic Stroke Patients
14. Direct Stenting of Intracranial Atherosclerosis-related Acute Large Vessel Occlusion
15. Pro‐Hemorrhagic Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy Associated with NOTCH3 p.R75P Mutation with Low Vascular NOTCH3 Aggregation Property.
16. Corrigendum to “D-dimer to fibrinogen ratio predicts early neurological deterioration in ischemic stroke with atrial fibrillation” [Thromb. Res. 229 (2023) 219–224]
17. Brain Frailty and Outcomes of Acute Minor Ischemic Stroke With Large-Vessel Occlusion
18. Differential Impacts of Admission LDL-Cholesterol on Early Vascular Outcomes by Ischemic Stroke Subtypes
19. Effectiveness of Adding Antiplatelets to Oral Anticoagulants in Patients with Acute Ischemic Stroke with Atrial Fibrillation and Concomitant Large Artery Steno-Occlusion
20. CHA2DS2-VASc score in acute ischemic stroke with atrial fibrillation: results from the Clinical Research Collaboration for Stroke in Korea
21. Interpretable machine learning for early neurological deterioration prediction in atrial fibrillation-related stroke
22. Association of Prestroke Glycemic Control With Vascular Events During 1-Year Follow-up
23. Regional availability of mechanical embolectomy for acute ischemic stroke in California, 2009 to 2010.
24. Intravenous thrombolysis with tissue-plasminogen activator in small vessel occlusion
25. Pathogenic NOTCH3 Variants Are Frequent Among the Korean General Population
26. Statin Treatment in Patients With Stroke With Low‐Density Lipoprotein Cholesterol Levels Below 70 mg/dL
27. Genetic Causes of Ischemic Stroke
28. Neurological Deterioration in Patients with Acute Ischemic Stroke or Transient Ischemic Attack
29. Three-month modified Rankin Scale as a determinant of 5-year cumulative costs after ischemic stroke: An analysis of 11,136 patients in Korea
30. Effect of Heart Rate on Stroke Recurrence and Mortality in Acute Ischemic Stroke With Atrial Fibrillation
31. CHADS2, CHA2DS2-VASc, ATRIA, and Essen stroke risk scores in stroke with atrial fibrillation: A nationwide multicenter registry study
32. Safety and Efficacy of Intravenous Thrombolysis in the 3- to 4.5-hour Window in Acute Ischemic Stroke Patients Who Have Both Diabetes Mellitus and History of Prior Stroke
33. Comparative Effectiveness of Dual Antiplatelet Therapy With Aspirin and Clopidogrel Versus Aspirin Monotherapy in Mild-to-Moderate Acute Ischemic Stroke According to the Risk of Recurrent Stroke: An Analysis of 15 000 Patients From a Nationwide, Multicenter Registry
34. Secular Trends in Outcomes and Impact of Novel Oral Anticoagulants in Atrial Fibrillation–Related Acute Ischemic Stroke
35. Utility of Items of Baseline National Institutes of Health Stroke Scale as Predictors of Functional Outcomes at Three Months after Mild Ischemic Stroke
36. Risk of recurrent stroke and antiplatelet choice in breakthrough stroke while on aspirin
37. Elevated troponin levels are associated with early neurological worsening in ischemic stroke with atrial fibrillation
38. Futile reperfusion and predicted therapeutic benefits after successful endovascular treatment according to initial stroke severity
39. Influence of Hemoglobin Concentration on Stroke Recurrence and Composite Vascular Events
40. Comparative Effectiveness of Dual Antiplatelet Therapy With Aspirin and Clopidogrel Versus Aspirin Monotherapy in Acute, Nonminor Stroke: A Nationwide, Multicenter Registry-Based Study
41. Characteristics of the Drip-and-Ship Paradigm for Patients with Acute Ischemic Stroke in South Korea
42. Comparative Effectiveness of Aspirin and Clopidogrel Versus Aspirin in Acute Minor Stroke or Transient Ischemic Attack
43. Dual antiplatelet Use for extended period taRgeted to AcuTe ischemic stroke with presumed atherosclerotic OrigiN (DURATION) trial: Rationale and design
44. Improvement in Delivery of Ischemic Stroke Treatments but Stagnation of Clinical Outcomes in Young Adults in South Korea
45. Optimal use of antithrombotic agents in ischemic stroke with atrial fibrillation and large artery atherosclerosis
46. Abstract 44: Impact Of Novel Oral Anticoagulant Use On Secular Trend Of Vascular Events Or Death After Atrial Fibrillation-related Acute Ischemic Stroke
47. A Case of Anterior Communicating Artery Aneurysm Impending Rupture Presenting with Isolated Painful Adduction Palsy Mimicking Ischemic Internuclear Ophthalmoplegia
48. Direct admission to stroke centers reduces treatment delay and improves clinical outcome after intravenous thrombolysis
49. Recurrent Stroke, Myocardial Infarction, and Major Vascular Events during the First Year after Acute Ischemic Stroke: The Multicenter Prospective Observational Study about Recurrence and Its Determinants after Acute Ischemic Stroke I
50. Dual Versus Mono Antiplatelet Therapy in Large Atherosclerotic Stroke: A Retrospective Analysis of the Nationwide Multicenter Stroke Registry
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.